This inventor holds 2 USPTO granted patents. Top assignee: Pro-Neuron, Inc.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Innovator Vladimir Kozlov: Pioneering Stem Cell Proliferation Inhibitors
Introduction
Vladimir Kozlov, an accomplished inventor based in Novosibirsk, Russia, has made significant contributions to the field of biotechnology. With two patents to his name, he has focused on developing innovative methods for stem cell regulation, which have potential therapeutic applications. His work is vital for advancing medical science and improving patient outcomes.
Latest Patents
Kozlov's most recent patents revolve around "Inhibitor of Stem Cell Proliferation and Uses Thereof." These patents disclose and claim methods for isolating and utilizing factors that inhibit stem cell proliferation. The technology aims to regulate abnormal stem cell cycles and facilitate recovery of peripheral blood cells following chemotherapy. This invention is particularly crucial for enhancing patient recovery and providing new avenues for treatment.
Career Highlights
Kozlov currently works at Pro-Neuron, Inc., a company dedicated to pioneering advancements in neurobiology. His work within this organization showcases his commitment to innovation in the field. Through his research and patent applications, he has positioned himself as a notable figure in biotechnology and regenerative medicine.
Collaborations
In his professional journey, Kozlov collaborates with Irena Tsyrlova, leveraging their combined expertise to push the boundaries of current scientific understanding. Their collaboration exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in research.
Conclusion
Vladimir Kozlov stands out as a significant inventor in the realm of stem cell research. His patents reflect an innovative approach to solving complex medical challenges. As he continues to work with Pro-Neuron, Inc. and collaborate with fellow scientists, the impact of his research promises to advance therapeutic possibilities for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile